No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Kairos Pharma Adds City of Hope Cancer Center for Phase 2 Env105 Clinical Trial
Express News | Kairos Pharma Ltd: Announced Its Approval to Dual List Its Shares on Upstream
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital
Kairos Pharma Is Maintained at Buy by D. Boral Capital
Kairos Pharma | 10-Q: Q3 2024 Earnings Report
Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
No Data